Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients
Authors:
- Katarzyna Marcisz-GrzankaKMKatarzyna Marcisz-Grzanka
- Beata KotowiczBKBeata Kotowicz
- Aleksandra NowakANAleksandra Nowak
- Mariola WiniarekMWMariola Winiarek
- Malgorzata FuksiewiczMFMalgorzata Fuksiewicz
- Maria KowalskaMKMaria Kowalska
- Andrzej TysarowskiATAndrzej Tysarowski
- Tomasz OlesinskiTOTomasz Olesinski
- Jakub PaluckiJPJakub Palucki
- Urszula SulkowskaUSUrszula Sulkowska
- Agnieszka Kolasinska-CwiklaAKAgnieszka Kolasinska-Cwikla
- Lucjan Stanislaw WyrwiczLWLucjan Stanislaw Wyrwicz
Open Access
Abstract
Background: Perioperative treatment is a gold standard in locally advanced gastric cancer or GEJ cancer in the Western population. Unfortunately, the response rate after neoadjuvant chemotherapy (NAC) remains limited. Moreover, there are currently no biomarkers enabling an individual prediction of therapeutic efficacy. The aim of this study was the identification of serum biomarkers of early response to NAC. Methods: We conducted this prospective study in the MSCNRIO in Warsaw, Poland. A total of 71 patients and 15 healthy volunteers gave informed consent. Complete blood count, carcinoembryonic antigen (CEA), carcinoma antigen 125 (CA125), carcinoma antigen 19.9 (CA19.9), and fibrinogen (F) were measured at baseline and before every cycle. Circulating tumour cells (CTCs) and interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-10 (IL-10) were measured in a pilot group of 40 patients at baseline and before cycle two (C2) and cycle three (C3). Results: Of all the measured parameters, only the IL-6 serum level was statistically significant. The IL-6 level before C2 of chemotherapy was significantly decreased in the complete pathological response (pCR) vs. the non-pCR group (3.71 pg/mL vs. 7.63 pg/mL, p = 0.004). In all patients with an IL-6 level below 5.0 pg/mL in C2, tumour regression TRG1a/1b according to the Becker classification and ypN0 were detected in postoperative histopathological specimens. The IL-6 level before C1 of chemotherapy was significantly elevated in ypN+ vs. ypN0 (7.69 pg/mL vs. 2.89 pg/mL, p = 0.022). Conclusions: The trial showed that an elevated level of IL-6 prior to treatment and C2 might be a predictor of pathological response to NAC.Keywords
All Related Versions
Funding Information
- Maria Sklodowska-Curie National Research Institute of Oncology (MSCNRIO) (SN/GW24/2017)
This publication has 59 references indexed in Scilit:
- Prognostic significance of post-preoperative tumor markers increments in patients with non-metastatic gastric cancerJournal of Cancer Research and Clinical Oncology, 2023
- Frequency and prognostic impact of cachexia during drug treatment for unresectable advanced gastric cancer patientsSurgery Today, 2022
- Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomasThe Journal of Pathology: Clinical Research, 2020
- A retrospective cohort study to investigate the incidence of cancer-related weight loss during chemotherapy in gastric cancer patientsSupportive Care in Cancer, 2020
- Clinical significance of circulating tumor cells in blood from patients with gastric cancerAnnals of Gastroenterological Surgery, 2017
- Prognostic implication of antitumor immunity measured by the neutrophil–lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancerGastric Cancer, 2016
- Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancerGastric Cancer, 2014
- Serum interleukin-6 and -10 levels in patients with gastric cancerGastric Cancer, 2009
- Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factorGastric Cancer, 2005
- Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinomaJournal of Biomedical Science, 2004